Matthew J. LeBaron
- Molecular Biology
- Oncology top 5%
- Cancer Research top 5%
- Genetics top 10%
- Health, Toxicology and Mutagenesis top 5%
- Co-authors
- Hallgeir RuiMarja T. NevalainenJianwu XieB. Bhaskar GollapudiReza J. RasoulpourAhmed SultanTommi J. AhonenKalle Alanen
- Topics
- Carcinogens and Genotoxicity Assessment (19 papers)Effects and risks of endocrine disrupting chemicals (11 papers)Pharmacogenetics and Drug Metabolism (10 papers)
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaNature Methods
- Partner nations
- United StatesIndiaFrance
In The Last Decade
Matthew J. LeBaron
53 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 605
- Oncology 476
- Cancer Research 343
- Genetics 193
- Health, Toxicology and Mutagenesis 190
Countries citing papers authored by Matthew J. LeBaron
This map shows the geographic impact of Matthew J. LeBaron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. LeBaron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. LeBaron more than expected).
Fields of papers citing papers by Matthew J. LeBaron
This network shows the impact of papers produced by Matthew J. LeBaron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. LeBaron. The network helps show where Matthew J. LeBaron may publish in the future.
Co-authorship network of co-authors of Matthew J. LeBaron
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. LeBaron. A scholar is included among the top collaborators of Matthew J. LeBaron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. LeBaron. Matthew J. LeBaron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 2 | |
| 3 | 8 | |
| 4 | 6 | |
| 5 | 14 | |
| 6 | 12 | |
| 7 | 4 | |
| 8 | 8 | |
| 9 | 1 | |
| 10 | 17 | |
| 11 | 10 | |
| 12 | 15 | |
| 13 | 29 | |
| 14 | 31 | |
| 15 | 43 | |
| 16 | 36 | |
| 17 | 21 | |
| 18 | 163 | |
| 19 | 108 | |
| 20 | 45 |
About Matthew J. LeBaron
Matthew J. LeBaron is a scholar working on Pharmacology, Cancer Research and Small Animals, having authored 53 papers that have together received 1.3k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (19 papers), Effects and risks of endocrine disrupting chemicals (11 papers) and Pharmacogenetics and Drug Metabolism (10 papers). The work is most often cited by research in Cancer Research (343 citations), Oncology (476 citations) and Chemical Health and Safety (10 citations). Matthew J. LeBaron has collaborated with scholars based in United States, India and France. Frequent co-authors include Hallgeir Rui, Marja T. Nevalainen, Jianwu Xie, B. Bhaskar Gollapudi, Reza J. Rasoulpour, Ahmed Sultan, Tommi J. Ahonen, Kalle Alanen, Martti Nurmi and M. Sue Marty. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.